Drmtlgy Radiance Powder
Product Images NDC 83286-191

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Drmtlgy Radiance Powder (NDC 83286-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Drmtlgy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Inactive Ingredients (Inactive Ingredients)

Inactive Ingredients (Inactive Ingredients)
Inactive ingredients panel of DRMTLGY Radiance Powder topical powder lists various components including Butylated Salicylate, Calcium Sodium Borosilicate, Caprylic/Capric Triglyceride, Caprylyl Glycol, Dimethicone, Dimethicone/Vinyl Dimethicone Crosspolymer, Glycerin, Glycyrrhiza Glabra (Licorice) Root Extract, Iron Oxides, Isohexadecane, Isohexyl Salicylate, Methicone, Niacin, Niacinamide, Octyldodecanol, Phenylpropanol, Physalis Angulata Extract, Polymethylsilsesquioxane, Propanediol, Resveratrol, Silica, Sodium Hyaluronate, Tocopherol, and Tridecyl Salicylate.*
FDA Label Image

Pdp (Pdp)

Pdp (Pdp)
Drug Facts label panel for DRMTLGY Radiance Powder topical sunscreen showing active ingredients Titanium Dioxide 12.50% and Zinc Oxide 22.50%. The panel includes sections for Uses, Warnings, Directions, Other Information, and Inactive Ingredients. Contact information for questions or comments is also provided.*
FDA Label Image

Active Ingredients (Active Ingredients)

Active Ingredients (Active Ingredients)
This image shows a Drug Facts panel excerpt listing the active ingredients titanium dioxide and zinc oxide, each indicated as a sunscreen agent. The text is black and white with clear headings for active ingredients and purpose but does not provide full Drug Facts details.*
FDA Label Image

Dosage And Administration (Directions)

Dosage And Administration (Directions)
The image shows a directions label panel for an OTC topical powder, instructing users to shake well, apply 15 minutes before sun exposure, and reapply regularly. It advises use with water-resistant sunscreen and caution for children under 6 months. Sun protection measures to limit sun exposure during peak hours are included.*
FDA Label Image

Indication And Usage (Uses)

Indication And Usage (Uses)
A small black text box containing partial text under the header 'Uses.' It indicates the product helps prevent sunburn when used with other sun protection measures and mentions reducing the risk of skin cancer and premature skin aging caused by the sun.*
FDA Label Image

Keep Out Of Reach Of Children (Warning)

Keep Out Of Reach Of Children (Warning)
A small black and white text panel labeled 'Warnings' with several bullet points for topical product use. It includes warnings about external use only, not using on damaged skin, avoiding contact with eyes, rinsing with water if in eyes, consulting a doctor for skin rash, and keeping out of reach of children with instructions for medical help or poison control if swallowed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.